Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial.  Watson DP, Swartz JA, Robison-Taylor L, Mackesy-Amiti ME, Erwin K, Gastala N, Jimenez AD, Staton MD, Messm…

Patient access to chronic medications during the Covid-19 pandemic: Evidence from a comprehensive dataset of US insurance claims.  Clement J, Jacobi M, Greenwood BN (2021)  PLoS ONE 16(4): e0249453. doi.org/10.1371/journal.pone.0249453…

The Impact of Stigma on Treatment Services for People With Substance Use Disorders During the COVID-19 Pandemic-Perspectives of NECPAM Members.  Dannatt L, Ransing R, Calvey T, Scheibein F, Saad NA, Shirasaka T, Ramalho R, Pant S, Vadivel R, S…

Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic.  Wang L, Weiss J, Ryan EB, Waldman J, Rubin S, Griffin JL.  J Subst Abuse Treat. 2021 May;124:108272. doi: 10.1016/j.jsat.2020.108272. Epub 2021 Jan…

Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island.  Clark SA, Davis C, Wightman RS, Wunsch C, Keeler LAJ, Reddy N, Samuels EA.  J Subst Abuse Treat. 2021 May;124:10828…

EMCDDA. EMCDDA trendspotter briefing: Impact of COVID-19 on drug use and drug services in Western Balkans Summary The Western Balkans (Albania, Bosnia and Herzegovina, Kosovo*, Montenegro, North Macedonia and Serbia) registered the main waves of C…